62.20

0.29% 0.345

Disc Medicine Inc (IRON)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$62.55

Aprire:

$63

Volume 24 ore:

6,856

Relative Volume:

0.02

Capitalizzazione di mercato:

$1.86B

Reddito:

Utile/perdita netta:

$-91.00M

Rapporto P/E:

-15.71

EPS:

-3.9598

Flusso di cassa netto:

$-74.38M

1 W Prestazione:

+3.40%

1M Prestazione:

+23.56%

6M Prestazione:

+100.67%

1 anno Prestazione:

+21.22%

Intervallo 1D:

$61.36

$63.63

Intervallo di 1 settimana:

$56.28

$63.63

Portata 52W:

$25.60

$77.60

Disc Medicine Inc Stock (IRON) Company Profile

Nome

Disc Medicine Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

(617) 674-9274

Indirizzo

321 ARSENAL STREET, SUITE 101, WATERTOWN

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

IRON's Discussions on Twitter

Confronta IRON con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IRON	62.70	1.86B	0	-91.00M	-74.38M	-3.9598
VRTX	447.51	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	741.90	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.12	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.68	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.20	24.49B	3.30B	-501.07M	1.03B	11.54

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-08-22	Iniziato	Wells Fargo	Overweight
2024-04-01	Downgrade	Raymond James	Strong Buy → Outperform
2023-12-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-06-09	Aggiornamento	Raymond James	Outperform → Strong Buy
2023-06-07	Iniziato	H.C. Wainwright	Buy
2023-05-17	Iniziato	Raymond James	Outperform
2023-04-28	Iniziato	Cantor Fitzgerald	Overweight
2023-04-21	Iniziato	Stifel	Buy
2023-04-20	Iniziato	Morgan Stanley	Overweight
2023-03-23	Iniziato	BMO Capital Markets	Outperform
2023-02-28	Iniziato	SVB Securities	Outperform

Mostra tutto

Disc Medicine Inc Borsa (IRON) Ultime notizie

Nov 20, 2024

Disc Medicine secures $200m financing to support trials - MSN

Nov 20, 2024

Contrasting Pharming Group (OTCMKTS:PHGUF) and Disc Medicine (NASDAQ:IRON) - Defense World

Nov 20, 2024

Nov 19, 2024

Disc Medicine chief medical officer sells $546,152 in stock - Investing.com

Nov 19, 2024

Disc Medicine chief medical officer sells $546,152 in stock By Investing.com - Investing.com UK

Nov 19, 2024

Paradigm Biocapital Advisors LP Adjusts Stake in Disc Medicine I - GuruFocus.com

Nov 15, 2024

Analysts Set Disc Medicine, Inc. (NASDAQ:IRON) PT at $85.80 - MarketBeat

Nov 15, 2024

Nov 14, 2024

FY2028 Earnings Forecast for Disc Medicine Issued By Wedbush - MarketBeat

Nov 14, 2024

Nov 13, 2024

Disc Medicine Reports Q3 2024 Results and Strategic Progress - TipRanks

Nov 13, 2024

Disc Medicine (NASDAQ:IRON) Announces Quarterly Earnings Results - MarketBeat

Nov 13, 2024

Disc Medicine to Participate in Upcoming Investor Conferences - The Manila Times

Nov 13, 2024

Disc Medicine stock gets price target bump from H.C. Wainwright, Buy rating intact - Investing.com UK

Nov 13, 2024

Disc Medicine (IRON) to Present at Major Healthcare Investor Conferences | IRON Stock News - StockTitan

Nov 13, 2024

Learn to Evaluate (IRON) using the Charts - Stock Traders Daily

Nov 13, 2024

Nov 12, 2024

Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024

Disc Medicine Secures $200M Financing, Reports FDA Fast-Track Potential for Key Drug | IRON Stock News - StockTitan

Nov 12, 2024